Motif Bio PLC (LSE:MTFB) - Share price


Stock Report

Motif Bio PLC MTFB

Latest Morningstar Commentary
DateAuthor Headline

Latest Company News

DateTimeSourceHeadlineType
Previous Stories...
06/12/201911:14LSEHolding(s) in CompanyHOL
29/11/201912:20LSEHolding(s) in CompanyHOL
29/11/201907:00LSETotal Voting RightsTVR
27/11/201907:00LSEADS Program and Warrant Agent AgreementMSC
26/11/201907:00LSEVoluntary Delisting from the Nasdaq Capital MarketMSC
20/11/201917:51LSEHolding(s) in CompanyHOL
18/11/201912:12LSEDirectorate ChangesBOA
14/11/201918:13LSEResult of General MeetingROM
11/11/201907:00LSESettlement AgreementAGR
28/10/201916:14LSEHolding(s) in CompanyHOL
25/10/201915:51LSEHolding(s) in CompanyHOL
25/10/201912:07LSESecond Price Monitoring ExtnAPM
25/10/201912:02LSEPrice Monitoring ExtensionPME
25/10/201907:00LSEPosting of Circular and Notice of General MeetingMSC
24/10/201907:00LSEU.S. Army-funded project to Evaluate IclaprimMSC
21/10/201915:00LSETiming of General Meeting and CircularMSC
21/10/201912:07LSESecond Price Monitoring ExtnAPM
21/10/201912:02LSEPrice Monitoring ExtensionPME
10/10/201907:00LSEMotif Bio confirms receipt of FDA meeting minutesMSC
03/10/201912:07LSESecond Price Monitoring ExtnAPM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.